How many insider declarations has Dr.C.S. VENKATESAN filed?

Dr.C.S. VENKATESAN has filed 3 public insider declarations with SEBI (PIT + SAST).

What is Dr.C.S. VENKATESAN's role?

Dr.C.S. VENKATESAN's reported role is not specified by the regulator across the filings.

Which companies does Dr.C.S. VENKATESAN report trades for?

Dr.C.S. VENKATESAN reports trades for Gland Pharma Limited.

← Executives ★ Sign in to follow

DV

Dr.C.S. VENKATESAN

·SEBI (PIT + SAST)

Gland Pharma Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the full record of transactions filed by Dr.C.S. VENKATESAN. Officer active across 1 company, notably Gland Pharma Limited. Cumulatively, 3 disclosures have been published. Activity tracked since 22 December 2023. The latest transaction was filed on 30 May 2024 (Sale). Regulator: SEBI (PIT + SAST). The full history is openly available.

Companies and markets linked to Dr.C.S. VENKATESAN

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Gland Pharma Limited (IN)IN insider transactions · SEBI (PIT + SAST)

Declarations3 total

●

Dr.C.S. VENKATESAN

Executives30 May 2024Gland Pharma Limited

₹9M7SEBI ↗

5,000 shares@ ₹1,837.2549.8% of flowEquity SharesSEBI:fb84231f42fae1d402874d82e748f8594efbd93f

●

Dr.C.S. VENKATESAN

Executives22 Dec 2023Gland Pharma Limited

₹3M4SEBI ↗

1,799 shares@ ₹1,872.493618.0% of flowEquity SharesSEBI:8e9b884a44d3c8f902ab36fd7f18f4fd5e9be9c5

●

Dr.C.S. VENKATESAN

Executives22 Dec 2023Gland Pharma Limited

₹6M5SEBI ↗

3,201 shares@ ₹1,881.550132.2% of flowEquity SharesSEBI:6dafc28429e8413de6d15e4f4fea2a56b5cae829

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DV

Dr.C.S. VENKATESAN

·SEBI (PIT + SAST)

Gland Pharma Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the full record of transactions filed by Dr.C.S. VENKATESAN. Officer active across 1 company, notably Gland Pharma Limited. Cumulatively, 3 disclosures have been published. Activity tracked since 22 December 2023. The latest transaction was filed on 30 May 2024 (Sale). Regulator: SEBI (PIT + SAST). The full history is openly available.